198 related articles for article (PubMed ID: 2845125)
21. Differential regulation of the HIV-1 LTR by specific NF-kappa B subunits in HSV-1-infected cells.
Schafer SL; Hiscott J; Pitha PM
Virology; 1996 Oct; 224(1):214-23. PubMed ID: 8862416
[TBL] [Abstract][Full Text] [Related]
22. Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site.
Verhoef K; Sanders RW; Fontaine V; Kitajima S; Berkhout B
J Virol; 1999 Feb; 73(2):1331-40. PubMed ID: 9882338
[TBL] [Abstract][Full Text] [Related]
23. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
Mondal D; Alam J; Prakash O
J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
[TBL] [Abstract][Full Text] [Related]
24. Induction of human interferon gene expression is associated with a nuclear factor that interacts with the NF-kappa B site of the human immunodeficiency virus enhancer.
Hiscott J; Alper D; Cohen L; Leblanc JF; Sportza L; Wong A; Xanthoudakis S
J Virol; 1989 Jun; 63(6):2557-66. PubMed ID: 2542571
[TBL] [Abstract][Full Text] [Related]
25. VBP and RelA regulate avian leukosis virus long terminal repeat-enhanced transcription in B cells.
Curristin SM; Bird KJ; Tubbs RJ; Ruddell A
J Virol; 1997 Aug; 71(8):5972-81. PubMed ID: 9223487
[TBL] [Abstract][Full Text] [Related]
26. Multiple transcriptional regulatory domains in the human immunodeficiency virus type 1 long terminal repeat are involved in basal and E1A/E1B-induced promoter activity.
Kliewer S; Garcia J; Pearson L; Soultanakis E; Dasgupta A; Gaynor R
J Virol; 1989 Nov; 63(11):4616-25. PubMed ID: 2529378
[TBL] [Abstract][Full Text] [Related]
27. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
28. Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1.
Mosca JD; Bednarik DP; Raj NB; Rosen CA; Sodroski JG; Haseltine WA; Hayward GS; Pitha PM
Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7408-12. PubMed ID: 2823260
[TBL] [Abstract][Full Text] [Related]
29. The GGTCA palindrome and cognate cellular factors in trans-regulation of human immunodeficiency virus long terminal repeat by herpes simplex virus.
Feng CP; Kulka M; Aurelian L
J Gen Virol; 1993 Apr; 74 ( Pt 4)():715-23. PubMed ID: 8385697
[TBL] [Abstract][Full Text] [Related]
30. A CNS-enriched factor that binds to NF-kappa B and is required for interaction with HIV-1 tat.
Taylor JP; Pomerantz RJ; Oakes JW; Khalili K; Amini S
Oncogene; 1995 Jan; 10(2):395-400. PubMed ID: 7838536
[TBL] [Abstract][Full Text] [Related]
31. Role of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat.
Harrich D; Garcia J; Wu F; Mitsuyasu R; Gonazalez J; Gaynor R
J Virol; 1989 Jun; 63(6):2585-91. PubMed ID: 2657100
[TBL] [Abstract][Full Text] [Related]
32. Stimulation of a human T-cell clone with anti-CD3 or tumor necrosis factor induces NF-kappa B translocation but not human immunodeficiency virus 1 enhancer-dependent transcription.
Hazan U; Thomas D; Alcami J; Bachelerie F; Israel N; Yssel H; Virelizier JL; Arenzana-Seisdedos F
Proc Natl Acad Sci U S A; 1990 Oct; 87(20):7861-5. PubMed ID: 2146676
[TBL] [Abstract][Full Text] [Related]
33. Pentoxifylline inhibits HIV-1 LTR-driven gene expression by blocking NF-kappa B action.
Biswas DK; Dezube BJ; Ahlers CM; Pardee AB
J Acquir Immune Defic Syndr (1988); 1993 Jul; 6(7):778-86. PubMed ID: 8509980
[TBL] [Abstract][Full Text] [Related]
34. cis-acting regulatory elements in the bovine immunodeficiency virus long terminal repeat.
Fong SE; Pallansch LA; Mikovits JA; Lackman-Smith CS; Ruscetti FW; Gonda MA
Virology; 1995 Jun; 209(2):604-14. PubMed ID: 7778292
[TBL] [Abstract][Full Text] [Related]
35. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1.
Majello B; De Luca P; Hagen G; Suske G; Lania L
Nucleic Acids Res; 1994 Nov; 22(23):4914-21. PubMed ID: 7800480
[TBL] [Abstract][Full Text] [Related]
36. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.
Doerre S; Sista P; Sun SC; Ballard DW; Greene WC
Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1023-7. PubMed ID: 8430069
[TBL] [Abstract][Full Text] [Related]
37. Transcription factor PRDII-BF1 activates human immunodeficiency virus type 1 gene expression.
Seeler JS; Muchardt C; Suessle A; Gaynor RB
J Virol; 1994 Feb; 68(2):1002-9. PubMed ID: 8289330
[TBL] [Abstract][Full Text] [Related]
38. Human herpes virus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer.
Ensoli B; Lusso P; Schachter F; Josephs SF; Rappaport J; Negro F; Gallo RC; Wong-Staal F
EMBO J; 1989 Oct; 8(10):3019-27. PubMed ID: 2573513
[TBL] [Abstract][Full Text] [Related]
39. Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes.
Krebs FC; Mehrens D; Pomeroy S; Goodenow MM; Wigdahl B
J Biomed Sci; 1998; 5(1):31-44. PubMed ID: 9570512
[TBL] [Abstract][Full Text] [Related]
40. The human immunodeficiency virus type 1 long terminal repeat is activated by monofunctional and bifunctional DNA alkylating agents in human lymphocytes.
Quinto I; Ruocco MR; Baldassarre F; Mallardo M; Dragonetti E; Scala G
J Biol Chem; 1993 Dec; 268(35):26719-24. PubMed ID: 8253807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]